Joel David Mayersohn

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Fort Lauderdale, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Joel David Mayersohn
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joel David Mayersohn

Form 4 holding Director

QSAM Biosciences, Inc.

Security class
COMMON STOCK
Shares / value
400,000
Estimated value
$1,200,000
Report date
15 Dec 2021
Price
$3.00
Ownership
Direct
Form 4 holding Director

CITIUS ONCOLOGY, INC.

Security class
Stock Option (Right to Buy)
Shares / value
250,000
Estimated value
$522,500
Report date
19 Sep 2025
Price
$2.09
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250,000
Form 4 holding Director

QSAM Biosciences, Inc.

Security class
Options to buy common stock
Shares / value
54,000
Estimated value
Report date
24 Aug 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Joel David Mayersohn

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .